These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 10521763)

  • 21. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
    Williams MA; Hickok DE; Zingheim RW; Luthy DA; Kimelman J; Nyberg DA; Mahony BS
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1032-7. PubMed ID: 1384333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
    Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
    Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
    Wenstrom KD; Owen J; Chu Dc; Boots L
    Am J Obstet Gynecol; 1999 Oct; 181(4):887-92. PubMed ID: 10521748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between maternal serum biomarkers and the risk of fetal chromosome copy number variants: a single-center retrospective study.
    Zhang M; Gao Y; Liang M; Wang Y; Guo L; Wu D; Xiao H; Lin L; Wang H; Liao S
    Arch Gynecol Obstet; 2024 Aug; 310(2):933-942. PubMed ID: 38814455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A.
    Spencer K; Aitken DA; Crossley JA; McCaw G; Berry E; Anderson R; Connor JM; Macri JN
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():447-54. PubMed ID: 7530437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome.
    Lieppman RE; Williams MA; Cheng EY; Resta R; Zingheim R; Hickok DE; Luthy DA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1852-6; discussion 1856-7. PubMed ID: 8317532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of inherited thrombophilia on second trimester combined aneuploidy screening test markers.
    Cıkman MS; Seckin KD; Karslı MF; Baser E; Cıkman DI; Cicek MN
    Arch Gynecol Obstet; 2015 Apr; 291(4):787-90. PubMed ID: 25223861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
    Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
    J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
    Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
    J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective prenatal serum screening for Down syndrome in Venezuela.
    Alvarez-Nava F; Soto M; Morales-Machín A; Rojas A; Urdaneta K; Cañizález J
    Int J Gynaecol Obstet; 2008 Dec; 103(3):241-5. PubMed ID: 18817910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
    Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
    Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated maternal serum alpha-fetoprotein, very low unconjugated oestriol, and very low human chorionic gonadotropin associated with recent fetal death.
    Walters CP; McKinnon WC
    Prenat Diagn; 1993 May; 13(5):423-4. PubMed ID: 7688120
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical significance of low levels of second-trimester maternal serum human chorionic gonadotropin.
    Santolaya-Forgas J; Burd LI; Burton BK
    Fetal Diagn Ther; 1994; 9(6):362-6. PubMed ID: 7880431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship of adverse pregnancy outcomes and a high risk serum screen for Down syndrome in the second trimester].
    Hu XY; Bian XM; Jiang YL; Liu SY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):427-30. PubMed ID: 22932108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.